Verma, Ahmad, Akhtar, and Singh: Out of pocket expenditure on cancer patients at a tertiary care hospital of Lucknow


Introduction

Generally, cancer burden is measured in terms of the health outcomes like morbidity and mortality. However, economic measures as well as burden are equally important for its outcome research.1 These include the cost of screening, diagnosis, services or lost wages incurred as a result of the disease and its treatment.2 The cost of cancer has gained considerable attention and importance at national as well as international level, given the rising healthcare costs and its financial consequences. High out-of-pocket expenditure (OOPE) and the indirect costs involved in cancer treatment often result in financial burden and toxicity.3, 4, 5

In India, every year, nearly seven hundreds thousands deaths are attributed to cancer.6 Diagnostics as well as treatment determine the direct medical cost of any disease. The direct non-medical costs along with indirect and intangible costs associated with cancer is also huge. In majority of patients, cancer diagnosis leads not only to a health and psychological burden but a major financial burden as well. In India, each year, nearly half out of more than a million newly diagnosed cancer patients are suitable for curative aimed cancer directed therapy. If for financial reasons, these patients do not seek or are reluctant for treatment, they are actually being denied of the cancer care benefits. This inability to bear expenses for cancer diagnosis and treatment impose greater hindrance to the cancer fighting efforts of the nation.7 Considering the increasing costs of cancer diagnostics and its therapeutic interventions, their formal assessment is imperative to structure value-based standard treatment guidelines.8 Economic evaluations are used for informing healthcare funds allocations to ensure best value for money being spent. For facilitating such analyses in priority settings, strong information system will need to be structured and implemented in place.9

The purpose of our study was to determine out-of-pocket expenditure (OOPE) incurred by cancer patients at a tertiary care cancer centre at King Georges Medical University, Lucknow. In the present study, we noted socio-demographic as well as economic characteristics of patients seeking care at the centre along with descriptive analysis of the involved direct and medical and nonmedical costs incurred by these patients.

Materials and Methods

A tertiary care hospital based cross-sectional observational and analytical study was conducted on 120 cancer patients attending surgical OPD, at King Georges Medical University, Lucknow, for one year, from July 2020 to November 2021. Participants were directly interviewed at the site of first contact with no follow-up. No intervention was done.

Inclusion criteria

  1. Patients of any age/sex diagnosed with cancer of any type.

  2. Patient who had completed the primary treatment of cancer in KGMU, Lucknow.

  3. Patient who gave consent to participate in the study.

Exclusion criteria

  1. Patient who had undertaken primary cancer treatment from any other hospital and are coming to KGMU only for follow-up or any therapy.

  2. Patient who did not give consent for the study.

Pre-designed, pre-tested, and semi-structured questionnaire was used to determine the socio demographic characteristics, economical details, cancer diagnosis details and out of pocket expenditure details related to the participants. All the questions with regard to charges incurred in the past on various aspects such as consultation, medicines, diagnostics, travel, and lodging were enquired retrospectively from the onset of symptoms to the registration of individual as a cancer patient in the cancer centre. OOPE was calculated based upon the collected data.

Statistical analysis

Data were analysed using SPSS software 23 and MS Excel 2017. The categorical variables were represented in the form of frequency tables. Median (IQR) was used as the measure of the central tendency for the continuous variables. Non-parametric tests of significance like the Man Whitney U test and Kruskal Wallis test were used for determining the difference between the median of two groups of the particular independent variables. Also, the chi-square test and Fischer exact test were used as a test of significance. Spearman’s correlation was used to show an association between independent and dependent variables. Linear regression was applied to know the variability of dependant variables due to significantly correlated variables.

Ethical consideration

Institutional ethical clearance was obtained before starting data collection. Informed consent was obtained from the participants. Data collected from participants were maintained confidentially. Institutional ethical clearance reference number: 101st ECM II B thesis/P81

The present study was done on cancer patients at Surgical oncology OPD, KGMU, Lucknow to study the economic burden on a cancer patient’s household by estimating Out-of-pocket expenditure (OOPE).

Result

We observed participants ’majority (about 70%) of participants belong to the 31 to 60 years age group while only two were less than 14 years. The mean age of the total participants in the study was 45±13.6 years. There was equal distribution of participants on basis of gender i.e. 60 each. We noticed majority (about 85%) were married. About 54.2% of them were residing > 100 km away from the study area (Lucknow) and about 2/3rd of participants resides in rural areas. Other Socio-demographic details have been tabulated (Table 1).

Table 1

Out-of-pocket expenditure according to socio-demographic details of participants

Socio-demographic profile

Frequency (n)

Percentage %

OOPE

#P value

(Rs.) Mean ± SD

(Rs.) Median (IQR)

Age

0 to 14 years

2

1.7

16651

16651

0.086

15 to 30 years

14

11.7

113422.28 ±115911.9

62601 (51851,87800)

31 to 45 years

48

40.0

106146 ±92751.35

71101 (52651,130126)

46 to 60 years

38

31.7

105823.68 ±68991.97

98101 (53151,121028.3)

61 to 80 years

18

15.0

116145.44 ±69975.17

95151 (53201,165151)

Gender

Male

60

50.0

102988.67 ±82333.8

73751 (52826,122301)

0.273

Female

60

50.0

110813.67 ±87671.13

87800 (48651,121551)

Current marital status

Never married

8

6.7

112251 147608.2

41351 (21076,132526)

` 0.060

Married

102

85.0

102630.62 ±78780.12

79051 (51626,119460)

Divorced/separated/ widow

10

8.3

146180.8 ±80559.3

121551 (95151,174700)

Residential address

Less than 100 km from Lucknow

55

45.8

98939.07 ±81339.68

65051 (47325.5,122901

0.017

More than 100 Km from Lucknow

65

54.2

113638.32 ±87640.08

98151 (53201,121651)

Type of residence

Rural

80

66.7

103365.45 ±74222.6

91475.5 (55976,121551)

0.121

Urban

40

33.3

113972.6 ±103412.6

59201 (47701,168351)

Religion

Hindu

102

85.0

109880.98 ±81322.33

87800 (53163.5,121651)

0.125

Muslim

18

15.0

90015.5 ±103268.8

55751 (26383,80800)

Category

General

52

43.3

84107.92 ±64375.51

60551 (44851,98151)

.087

OBC

39

32.5

118963.7 ±90204.4

99151 (66851,154851)

SC/ST

29

24.2

131549.75 ±100785.4

106501 (53151,174700)

Type of family

Nuclear family

56

46.7

106764.6 ±94190.17

73701 (47701,113787.8)

0.143

Joint family

64

53.3

107020.65 ±76357.87

91475.5 (55151,147751)

[i] #Mann Whitney/ Kruskal Wallis test

We observed 77.5% of the total had studied till intermediate while 22.5% of participants more than intermediate. Majority (37.5%) were either unemployed or were housewives while only 5% were with job. (Table 2)

Table 2

Out-of-pocket expenditure according to qualification and occupational details of participants

Socio-demographic profile

Frequency

Percentage

OOPE

#P value

(Rs.) Mean ± SD

(Rs.) Median (IQR)

Highest education qualification

Illiterate

8

6.7

69513 ±22429.29

67000.5 (51400.75, 85112.75)

0.074

Literate but no formal education

19

15.8

128649.2 ±90911.27

111200 (55751, 154851)

Till Primary school

10

8.3

195411 ±128570.9

124251 (121551, 279451)

Till middle school

6

5.0

50117.67 ±26627.1

60051 (27501, 70251)

High school

18

15.0

129145.3 ±85691.93

101651 (51851, 174700)

Intermediate

32

26.7

100174.75 ±84881.94

74801 (52251, 113712.5)

Diploma

6

5.0

70651 ±35555.59

53151 (45276, 100401)

Graduate

6

5.0

62084.3 ±17298.4

53351 (49826, 76526)

Postgraduate and above

15

12.5

83084.3 ±52107.74

79051 (40551, 102151)

Occupation of the patient

Professional/technical/ administrative/ managerial

6

5.0

75017.67 ±25830.27

84251 (53051, 94676)

0.325

Sales and service

12

10.0

73481.17 ±29507.58

76425.5 (53351, 102151)

Skilled

6

5.0

34934.33 ±16913.09

36251 (20613.5, 48926)

Unskilled

16

13.3

121800.75 ±83420.59

92475.5 (64626, 134913.3)

Agriculture

26

21.7

129362.3 ±108473.9

80800 (68451, 124251)

Unemployed/ Housewife

45

37.5

112436.95 ±89050.94

95151 (41751, 154851)

Retired Pensioner

9

7.5

101639.88 ±55438.85

116151 (48651, 165151)

[i] #Mann Whitney/ Kruskal Wallis test

About 18.3 percent of study participants had to spend extra on another family member who is suffering from some chronic illness other than the present cancer patient. Only 8.3 percent of study participants’ family already taken loans for some other purpose. We observed the mean family income of study participants was Rs 16125 ± 19105.33 whereas the mean per capita income of study participants was Rs 2776.18.

After applying modified BG Prasad classification10 most of the study participants belonged to Classes V (44.2%) followed by class IV (23.3%) (Table 3). The highest monthly per capita income of participants’ households was for a class I socio-economic class i.e. Rs 13720.93 whereas the lowest was for Class IV i.e., Rs 1679.48. On average, mean per capita income (MPCI) is Rs 2776.18 (Figure 1).

Table 3

Out-of-pocket expenditure of the different socio-economic group according to B G Prasad classification

Subclass

Frequency (n)

Percentage (%)

OOPE

#p-value

(Rs.) Mean ± SD

(Rs.) Median (IQR)

Class I

11

9.16

100496.5 ± 45494.4

84251 (73751,133651)

0.506

Class II

16

8.33

78258.38 ± 64231.06

51001 (32826,119982.8)

Class III

12

10.0

149234.5 ± 111065.5

111151 (53151,236551)

Class IV

28

23.33

119810.4 ± 95990.48

88601 (41751,154851)

Class V

53

44.16

100472.5 ± 81604.57

75851 (53201,111200)

[i] #Kruskal Wallis test

Graph 1

Distribution of Monthly per capita income (MPCI) of participant’s household according to Socio-economic class (B G Prasad classification) (N=120)

https://typeset-prod-media-server.s3.amazonaws.com/article_uploads/c1d05742-aeb4-495d-838b-e21da590c85b/image/95170799-913a-40e2-92b6-78bc270eb7ed-uimage.png

Majority (45.8%) were suffered from oral cancer. A majority (61.7%) of them were diagnosed at Medical Colleges. Most participants (81.7%) were diagnosed with cancer after being symptomatic for the disease. About 36.7% of the participants’ treatment plan was surgery plus chemotherapy plus radiotherapy while 8.3%were planned for chemotherapy and radiotherapy.

Table 4

Out-of-pocket expenditure according to details of diagnosis of participants

Details of diagnosis

Frequency (n)

Percentage %

OOPE

#p-value

(Rs.) MEAN ± SD

(Rs.) Median (IQR)

Site of cancer

Oral

49

40.8

107664.79 ±58269.05

98051 (68451,124251

0.001

Breast

13

10.8

89424.07 ±69067.76

79051 (36251,147751)

Ovary

14

11.7

113701 ±111331.6

55751 (49788.5,155776)

Tongue

12

10.0

45992.67 ±18043.54

46601 (41751,51851)

Gall bladder

8

6.7

153613.25 ±119381.5

113851 (46000,176351)

Others

24

20.0

125725.83 ±113340.4

92975.5 (49876,142537.8)

Facility at which cancer was diagnosed

Medical college/District hospital

76

62.3

76876.01 ±52175.09

60051 (42651,98051)

<0.001

Pvt hospital/Clinic

44

37.7

154953.08 ±105435

111200 (68451,174700)

When was cancer diagnosed

During screening/

22

18.3

125800.9 ±96787.62

98151 (72401,141201)

0.034

Symptomatic for cancer

98

81.7

102658.36 ±81792.53

73751 (50551,121103.3)

Time lost from first symptoms to making diagnosis

Within 1 month

55

45.8

109994.23 ±880602.18

87800 (49601,124251)

0.535

2 to 5 months

48

40.0

92688.75 ±65660.88

71001 (51776,107413.3)

6 to 12 months

7

5.8

147986.42 ±115230.5

111200 (74576,211025.5)

More than 1 year

10

8.3

129351 ±116418.8

79051 (73751,84251)

Delay in treatment after diagnosis

Yes

32

26.7

75760.25 ±77655.63

52376 (41076,84387.75)

0.023

No delay

88

73.3

118225.13 ±84827.07

99901 (59051,154851)

Treatment plan

Surgery + radiotherapy

16

13.3

93017.25 ±50223.5

78325.5 (65675,125826)

0.961

Chemotherapy + radiotherapy

10

8.3

83250.8 ±28877.85

87800 (53201,102151)

Surgery + chemotherapy+ Radiotherapy)

44

36.7

102375.22 ±80857.1

88551 (41151,130126)

Only surgery

32

26.7

109893.43 ±81728.58

79001 (59051,113812.8)

Surgery + Chemotherapy

18

15.0

143512 ±130166.7

68451 (53151,187651)

[i] #Kruskal Wallis/Mann Whitney U test

Overall mean out-of-pocket expenditure by study participants was Rs 79925.5(51776-121651). Out of which expenditure done before coming to tertiary care hospital was Rs 9000(2700-35500), under this Rs 8000(2500-30000) was spent as a medical expense and Rs 1200(500-5000) as a non-medical expense. On average total expenses at a tertiary care hospital were Rs 54551(34138.25-110051). Other expenses shown in Table 5.

Table 5

Details of out-of-pocket expenditure of participants

OOPE

(Rs.) Mean ± SD

(Rs.) Median (IQR)

Expenses before coming to tertiary care hospital(a)

(a.1) Medical expenses

22639.17 ±38326.9

8000(2500,30000)

(a.2) non-medical expenses

4998.33 ±8761.22

1200(500,5000)

(a)Total = (a.1) + (a.2)

27775.83 ±44686.55

9000(2700,35500)

Expenses after coming to tertiary(b)= (b.1) + (b.2)

84046.58 ±7627.3

54551(34138.25,110051)

Medical expenses (b.1)

Fees

189.91 ± 131.02

151(51,200)

Medicines and equipment’s

50066.67 ±49585.67

32500(19750,66250)

Investigations

15316.67 ±10673.13

15000(10000,20000)

(b.1) Total

65454.91 ±58752.7

45151(30051,90051)

Non- Medical expenses (b.2)

Transport

7499.16 ±12706.17

3600(2000,6000)

Food and lodging

6852.5 ±6032.45

5000(3000,8500)

(b.2) Total

14465 ±18143.9

10000(5000,14000)

Follow up expenditure (c) (Taking single follow up visit)

(c.1) Medical expenses

1600.41 ±3160.28

1000(700,2000)

(c.2) non-medical expenses

1020 ±1108.9

700(400,1200)

Mean expenditure per visit (c) = (c.1) +(c.2)

2630.4 ±3412.7

1800(1300,2525)

OOPE

Total (a+b+c)

1006901.17±84777.76

79925.5(51776,121651)

The OOPE increases with an increase in age group, minimum OOPE being for 0 to 14 years age group and maximum OOPE for 46 to 60 years age group, although it was statistically non-significant. OOPE was more for participants who were divorced/separated/widow but was found statistically non-significant. For participants who resided in an area that is more than 100 km from tertiary care hospital, Lucknow, had to spend more OOPE than those who resided within 100 km from tertiary care hospital, and it was found to be statistically significant (p = 0.017). OOPE was more for SC/ST category than the General /OBC category although it’s statistically non-significant. (Table 1) There is positive correlation between median OOPE and facility at which cancer was diagnosed that is if cancer is diagnosed in a private clinic/hospital more OOPE will be done by a cancer patient (Spearman coefficient = 0.407, P < 0.001).

OOPE was more for those who have a low level of education (illiterate to intermediate level) and less for those who are diploma/graduate/post-graduate, although it is statistically non-significant.(Table 2)

OOPE was more for participants who suffered from gall bladder cancer as compared to those who suffered from tongue cancer and it was found to be statistically significant (p = 0.001). Participants who were diagnosed with cancer while screening or by chance had to spend more OOPE than those who were diagnosed when they were symptomatic for cancer and it was statistically significant (p = 0.034). (Table 4)

Participants who were diagnosed at district hospital/medical college had to spend significantly less (p < 0.001) than those who were diagnosed at Private clinic/hospital and, those who had to suffer the delay in treatment due to some reason had to spend less than those who started treatment just after the diagnosis, and it was statistically significant (p=0.023). (Table 4) The OOPE for Class III socio-economic class was maximum followed by Class II socio-economic class (minimum), although it was statistically non-significant (p = 0.506.(Table 3)

Discussion

The ultimate concern for which the study was conducted was that people had to spend a heavy amount of money on cancer treatment and management which may lead to subsequent impoverishment, although some options and financial benefits are available for cancer patients its accessibility is still a problem.

The present study was performed in the tertiary care hospital of Lucknow district, recruiting 120 participants from surgical oncology OPD. The mean age of participants was 45±13.6 years with an equal number of males and females and most of the participants were married. According to Mathur et al. (2020)11 there was a similar risk of cancer (1 in 9) among males and females. One-third of participants were from a rural area and about half of them lived in the districts which are located 100 km from Lucknow. Khan abas et al. (2020)12 shows that majority of cancer patients were married and belonged to rural area. About half of them lived in a joint family, the majority belonging to the Hindu religion. Participants were mostly educated till intermediate and were agricultural workers/ unemployed or housewife with MPCI of Rs 2776.2 maximally belonging to class V socio-economic group. Khan abas et al. (2020)12 also show that the majority (80%) of cancer patients belong to a low socio-economic class. Most of the participants were of oral cancer, diagnosed mostly at medical colleges, and were given chemotherapy, radiotherapy, and surgical intervention. Similarly, Mathur et al. (2020)11 in study shows that one of the leading cancers in India is Oral cancer.

In this study, at first, we tried to estimate the Out-of-pocket Expenditure done by the cancer patients who visited and were treated at the tertiary care hospital of Lucknow. OOPE was estimated summing up the direct and indirect expenditure done at three steps- 1) Before coming to tertiary care hospital 2) at tertiary care hospital and 3) during one follow-up visit. Details of medical expenditure i.e., the fee paid, medicines/dyes/chemo drugs, equipment’s/instruments purchased, procedure/ surgery costing, investigations cost etc. and details of non-medical expenditure like travel expenses, food and accommodation expenses were taken. The OOPE estimated in a study is Rs 79925.5 (51776, 121651) which is about double that estimated in the study Bindu et al (2011).13

The present study also included expenditure did before coming to tertiary care hospital and also expenditure did during follow up visit and also there have been increase in cost of products at a market or even in hospital since there is a gap of a decade in between the cited study. In an article what is the cost of cancer in India? Published in the magazine The WEEK stated that at the National level, the total cancer care cost at the public hospital was Rs 72,092 and while it is more in states like Uttar Pradesh.14 Also Anushikha et al (2021)15 shows that direct OOPE on inpatient cancer care was Rs 83396.07. The majority part of OOPE was done after coming to tertiary care hospitals. In the study, participants on average spent Rs 45151(30051, 90051) on direct medical expenses which is about 82.8 percent of total cancer treatment expenses in hospitals. This is comparable to the result of the study done by Rajpal et al. (2014)16 which showed that the medical expenditure is estimated to be around 80-90 of total expenditure on cancer inpatient treatment. The OOPE done by participants before reaching to tertiary care hospital was done at different medical centers in search of making correct diagnosis and treatment and other expenses related to it, on average it was estimated Rs 9000(2700,35500), while in a study Bindu et al (2011)13 mean cost of expenses before coming to hospital was Rs 14031, it was estimated slightly more than the study done, due to positive change in health-seekingbehaviour of participants, directly reaching to medical centers where the diagnosis is made early and people reach desired tertiary care hospital early. And also, there has been an increase in the number of health centers and doctors, increasing their availability and accessibility. The expense made during follow-up visits after completing primary cancer treatment was also a contribution to OOPE although in the present study it was estimated mere Rs 1800 per visit the total expense may vary according to the frequency of follow-up visits. Per visit on average a participant spends Rs 1000 on medical and Rs 700 on non-medical, although data on the follow-up visit of cancer is not sufficiently available.

In the present study, the mean age of participants was 45 ±13.6 years, estimation of OOPE shows that female patients had to spend more than male patients which are in accordance with Rajpal et al (2014)16 study which also mentions that total expenditure on cancer treatment in males is Rs 27427 and in females is Rs 30835 which is higher than that in male. OOPE for the participants whose home town district is more than 100 km from the tertiary care hospital, Lucknow was more than those participants who resided within 100 km from tertiary care hospital which is supported by the study Emily et al (2019) which says that indigenous people with cancer have half the OOPE than non-indigenous people in Australia.17 Travel expenses and accommodation/food charges increase if the patient’s residence is far away from the treatment center. Participants residing in urban areas have to do less OOPE than participants residing in rural areas as the household income of urban areas is higher and good medical facilities are available in urban areas and more health awareness. Total OOPE was estimated to be more in gall bladder cancer and oral cancer, this may be due to more interventions needed in its management, and it’s difficult to diagnose in the early stages. As the charges are higher in private clinics or hospitals, all those who were diagnosed in the Private sector spend more OOPE than those who were diagnosed at public health centers.

One of the limitation of present study was small sample size and the result cannot be generalised as the sample was not the true representation of all population. Also, response of the participants could not be verified by records.

Conclusion

We concluded that cancer patients face the burden of out of pocket expenditure at every stage, beginning from the initial visit to a health care facility till the final diagnosis and treatment. Wenoticed The estimated OOPE is Rs 79925.5 (51776,121651) in comparison with MPCI of Rs. 2776.20. We documented significantly higher OOPE in gall bladder cancer treatment, treatment at private hospital / clinic, if diagnosed at screening time and if started treatment without delay. We recommend for strategic policy action to invest on reducing the economical burden of direct non-medical expenses and further study with large sample size.

Source of Funding

None.

Conflict of Interest

None.

References

1 

K Sharma S Das A Mukhopadhyay GK Rath BK Mohanti Economic cost analysis in cancer management and its relevance todayIndian J Cancer20094631849

2 

DG Fryback BM Craig Measuring economic outcomes of cancerJ Natl Cancer Inst Monogr20043313441

3 

R Lentz A B Benson S Kircher Financial toxicity in cancer care: prevalence, causes, consequences, and reduction strategiesJ Surg Oncol201912018592

4 

K Mehlis J Witte B Surmann M Kudlich L Apostolidis J Walther The patient-level effect of the cost of Cancer care - financial burden in German Cancer patientsBMC Cancer2020201529

5 

PM Carrera HM Kantarjian VS Blinder The financial burden and distress of patients with cancer: understanding and stepping-up action on the financial toxicity of cancer treatmentCA Cancer J Clin201868215365

6 

MK Mallath DG Taylor RA Badwe GK Rath V Shanta CS Pramesh The growing burden of cancer in India: epidemiology and social contextLancet Oncol201415620512

7 

W Joe A Kumar S Rajpal Economic burden of cancer in India: Evidence from cross-sectional nationally representative household surveyPLoS One2014132e0193320

8 

PC Smith Measuring for value for money in health care: concepts and tools2009The Health FoundationLondonhttps://www.lampdevelopment.org/wp-content/uploads/2017/01/MeasuringValueForMoneyInHealthcareConceptsAndTools.pdf

9 

L Downey N Rao L Guinness M Asaria S Prinja A Sinha Identification of publicly available data sources to inform the conduct of health technology assessment in IndiaF1000Res2018724510.12688/f1000research.14041.2

10 

P Mathiyalagen P Davis M Sarasveni Updated BG Prasad Socio-Economic Classification: The 2020 UpdateIndian J Pediatr2021881767

11 

P Mathur K Sathishkumar M Chaturvedi P Das KL Sudarshan S Santhappan Cancer Statistics, 2020: Report From National Cancer Registry Programme, IndiaJCO Glob Oncol202066106375

12 

A Khan FA Jan H Rashid Socio Demographic Profile of Cancer Patients attending tertiary care teaching hospital of IndiaJ Med Dent Sci Res202078610

13 

BK Mohanti A Mukhopadhyay S Das K Sharma S Dash Estimating the Economic Burden of Cancer at a Tertiary Public Hospital: A Study at the All India Institute of Medical Sciences2011 Indian Statistical InstituteDelhi

14 

PK Singh S Singh What is the cost of cancer care in India?The Week26Feb2020https://www.theweek.in/news/health/2020/02/26/what-is-the-cost-of-cancer-care-in-india.html

15 

A Dhankhar R Kumari YA Bahurupi Out-of-Pocket, Catastrophic Health Expenditure and Distress Financing on Non-Communicable Diseases in India: A Systematic Review with Meta-AnalysisAsian Pac J Cancer Prev202122367180

16 

S Rajpal A Kumar W Joe Economic burden of cancer in India: Evidence from cross-sectional nationally representative household surveyPLoS One2014132e0193320

17 

E Callander N Bates D Lindsay S Larkins SM Topp J Cunningham Long-term out of pocket expenditure of people with cancer: comparing health service cost and use for indigenous and non-indigenous people with cancer in AustraliaInt J Equity Health2019183210.1186/s12939-019-0931-4



jats-html.xsl


This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.

  • Article highlights
  • Article tables
  • Article images

Article History

Received : 07-05-2023

Accepted : 07-06-2023


View Article

PDF File   Full Text Article


Downlaod

PDF File   XML File   ePub File


Digital Object Identifier (DOI)

Article DOI

https://doi.org/10.18231/j.ijfcm.2023.011


Article Metrics






Article Access statistics

Viewed: 457

PDF Downloaded: 152



Medical Abbreviation List